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ABSTRACT
Dialysis-related amyloidosis predominantly occurs in osteo-articular structures and dialysis-related amyloid (DRA) substances 
also deposit in extra-articular tissues. Clinical manifestations of DRA include odynophagia, gastrointestinal hemorrhage, 
intestinal obstruction, kidney stones, myocardial dysfunction, and subcutaneous tumors. The pathological characteristics 
of DRA in the heart of hemodialysis patients have rarely been reported. We report the case of a 73-year-old female 
with a history of cerebral palsy and end-stage renal disease status post two failed renal transplants who had been on 
hemodialysis for 30 years. The patient was admitted with the working diagnosis of pneumonia. An echocardiography 
showed markedly reduced biventricular function manifested by low blood pressure with systolic in the 70s and elevated 
pulmonary artery pressure of 45 mmHg, which did not respond to therapy. Following her demise, the autopsy revealed 
bilateral pulmonary edema and pleural effusions. There was cardiac amyloid deposition exclusively in the coronary arteries 
but not in the perimyocytic interstitium. Amyloids were also found in pulmonary and intrarenal arteries and the colon wall. 
Previous case reports showed that beta 2-microglobulin amyloid deposits in various visceral organs but less frequently in 
the atrial and/or the ventricular myocardium. In the present case, amyloids in the heart were present in the intramural 
coronary arteries causing myocardial ischemia and infarction, which was the immediate cause of death. 
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CASE REPORT
A 73-year-old African American woman was 
referred to our hospital from her nursing home for 
complaints of shortness of breath. She had been 
on hemodialysis for 30 years because of end-stage 
renal dysfunction due to chronic glomerulonephritis. 
She had developed dialysis-related amyloid substance 
deposition in her shoulder and wrist joints and 
previously underwent bilateral carpal tunnel surgery. 
The patient was admitted to hospital with the working 
diagnosis of healthcare-associated pneumonia and was 
treated with antibiotics. During her hospital course, 
she developed low blood pressure and tachycardia. 
An electrocardiogram showed acute ST segment 
elevation and atrial fibrillation with ventricular 
tachycardia. The troponin determination was elevated. 
An echocardiogram revealed decreased bi-ventricular 
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systolic function, which was diffuse; the echo pattern 
and thickness of the myocardium were within normal 
limits.
Unfortunately, the patient died, and an autopsy 
was performed. Pathological findings showed severe 
amyloid deposition in almost all major organs including 
the intramural coronary vessels. On gross examination, 
the heart showed a recent lateral left ventricular wall 
infarction, multifocal myocardial replacement fibrosis, 
and amorphous eosinophilic intimal deposits in the 
intramural arteries (Figure 1) causing severe stenosis.
Amyloid deposition was exclusively in the coronary 
arteries but not in the perimyocytic interstitium. 
Stains for Congo red (Figure 2A) and the amyloid 
Figure 1. Photomicrograph of the heart showing coronary artery deposition of amyloid filling the lumen (H&E).
Figure 2. Photomicrograph of the heart showing coronary artery deposition of amyloid. A - Congo red; B - Amyloid 
P staining.
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P component (Figure 2B) were positive for amyloid 
deposition in virtually all intramyocardial arteries. 
Mass spectrometry characterized the amyloids as 
beta 2-microglobulin, compatible with dialysis-related 
amyloidosis.
DISCUSSION
Patients with long-term hemodialysis often 
develop dialysis-related amyloid (DRA), the cause of 
which is deposition of amyloid fibrils consisting of 
beta 2-microglobulin.1-3 Previous case reports have 
shown that beta 2-microglobulin is deposited in 
various visceral organs and is less frequently involved 
the heart.3-5 Especially in the cardiac involvement of 
DRA, beta 2-microglobulin is deposited in all layers 
of the atria and/or the ventricle.6-8 In the present 
case, we found exclusively intramural coronary vessel 
involvement of DRA at autopsy.
The features of cardiac amyloidosis between 
primary amyloidosis and DRA are quite different. 
In patients with hemodialysis-related amyloid substance 
deposition, even if the echocardiogram does not 
suggest any cardiac amyloidosis, physicians should 
consider the possibility of coronary amyloidosis and 
should check the details of cardiac findings as they 
may result in cardiac symptoms.
Early amyloidosis without myocardial involvement 
can produce acute coronary syndrome through the 
combination of spastic epicardial coronary arteries and 
obstruction of the intramural coronary arteries. In the 
management of certain patients with acute coronary 
syndrome, the possibility of cardiac amyloidosis should 
be taken into consideration.
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